MEDIROM Healthcare Technologies Inc. (NasdaqCM:MRM) entered into a share transfer agreement to acquire ZACC Kabushiki-Kaisha from all of the existing shareholders of ZACC Kabushiki-Kaisha for ¥370 million on August 31, 2021. MEDIROM Healthcare Technologies will acquire 100% of the shares of ZACC through a two-stage acquisition for total consideration of ¥370 million. The purchase price will be paid by cash on hand, and an initial payment of ¥69,013,698 was made on August 31, 2021. Payments of ¥152,986,302 and ¥148,000,000 will be made on October 1, 2021 and January 1, 2022, respectively. In the first stage, the shareholders of ZACC will transfer 60% of the common shares of ZACC to MEDIROM. At the second stage, the remaining shares of ZACC will be transferred to MEDIROM. The first stage of the acquisition is scheduled to close on October 1, 2021. The second stage is scheduled to close on January 1, 2022.

MEDIROM Healthcare Technologies Inc. (NasdaqCM:MRM) completed the acquisition of ZACC Kabushiki-Kaisha from all of the existing shareholders of ZACC Kabushiki-Kaisha in January 2022.